M. Schuemie

First name
M.
Middle name
J.
Last name
Schuemie
Voss, E. A., Shoaibi, A., Lai, Y. H., Blacketer, C., Alshammari, T., Makadia, R., et al. (2023). Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a multinational retrospective cohort study. Eclinicalmedicine, 58, 101932. http://doi.org/10.1016/j.eclinm.2023.101932
Voss, E. A., Ali, S. R., Singh, A., Rijnbeek, P. R., Schuemie, M. J., & Fife, D. (2022). Hip Fracture Risk After Treatment with Tramadol or Codeine: An Observational Study. Drug Saf, 45, 791-807. http://doi.org/10.1007/s40264-022-01198-9
Weinstein, R. B., Ryan, P. B., Berlin, J. A., Schuemie, M. J., Swerdel, J., & Fife, D. (2020). Channeling Bias in the Analysis of Risk of Myocardial Infarction, Stroke, Gastrointestinal Bleeding, and Acute Renal Failure with the Use of Paracetamol Compared with Ibuprofen. Drug Saf. http://doi.org/10.1007/s40264-020-00950-3
Schuemie, M. J., Weinstein, R., Ryan, P. B., & Berlin, J. A. (2021). Quantifying bias in epidemiologic studies evaluating the association between acetaminophen use and cancer. Regul Toxicol Pharmacol. http://doi.org/10.1016/j.yrtph.2021.104866